Mesothelioma risk and environmental exposure to asbestos: Past and future trends in Japan

International Journal of Occupational and Environmental Health

Volumn 15, Issue 2, 2009, Pages 166-172

  Azuma, Kenichi ^a   Uchiyama, Iwao ^b   Chiba, Yasutaka ^a   Okumura, Jiro ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Asbestos; Environment; Environmental exposure; Mesothelioma; Mortality; Risk

Indexed keywords

ASBESTOS;

AIR POLLUTANT; ARTICLE; BIOLOGICAL MODEL; CHEMICALLY INDUCED DISORDER; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; FORECASTING; HUMAN; INCIDENCE; JAPAN; LUNG TUMOR; MESOTHELIOMA; MORTALITY; RISK FACTOR;

AIR POLLUTANTS; ASBESTOS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; FORECASTING; HUMANS; INCIDENCE; JAPAN; LUNG NEOPLASMS; MESOTHELIOMA; MODELS, BIOLOGICAL; RISK FACTORS;

EID: 67651046725     PISSN: 10773525     EISSN: None     Source Type: Journal    
DOI: 10.1179/oeh.2009.15.2.166     Document Type: Article

References (56)

1. International Programme on Chemical Safety. Asbestos and Other Natural Mineral Fibres. Environmental Health Criteria 53. Geneva: World Health Organization; 1986.
2. Virta RL. Worldwide Asbestos Supply and Consumption Trends from 1900 through 2003. US Geological Survey Open-File Report 03-083. Reston. Virginia: US Department of the Interior and US Geological Survey; 2003.
3. LaDou J. The Asbestos Cancer Epidemic. Environ Health Perspect. 2004;112:285-90.
4. Robinson B WS, Musk AW, Lake RA. Malignant mesothelioma. Lancet. 2005;366:397-408.
5. Peto J, Matthews FE, Hodgson JT, Jones JR. Continuing increase in mesothelioma mortality in Britain. Lancet. 1995;345:535-39.
6. Bianchi C, Giarelli L, Grandi G, Brollo A, Ramani L, Zuch C. Latency periods in asbestos-related mesothelioma of the pleura. Eur J Cancer Prev. 1997;6:162-66.
7. Järvholm B, Englund A, Albin M. Pleural mesothelioma in Sweden: an analysis of the incidence according to the use of asbestos. Occup Environ Med. 1999;56:110-13.
8. McElvenny DM, Darnton AJ, Price MJ, Hodgson JT. Mesothelimoa mortality in Great Britain from 1968 to 2001. Occup Med. 2005;55:79-87.
9. Pelucchi C, Malvezzi M, Vecchia CL, Levi F, Decarli A, Negri E. The Mesothelimoa epidemic in Western Europe: an update. Br J Cancer. 2004;90:1022-24.
10. Montanaro F, Bray F, Gennaro V, Merler E, Tyczynski JE, Parkin DM, the ENCR working group. Pleural mesothelioma incidence in Europe: evidence of some deceleration in the increasing trends. Cancer Cause Control. 2003;14:791-803.
11. Price B, Ware A. Mesothelioma Trends in the United States: An Update Based on Surveillance, Epidemiology, and End Results Program Data for 1973 through 2003. Am J Epidemiol. 2004;159:107-12.
12. Murayama T, Takahashi K, Natori Y, Kurumatani N. Estimation of Future Mortality From Pleural Malignant Mesothelioma in Japan Based on Age-Cohort Model. Am J Ind Med. 2006;49:1-7.
13. Price B. Analysis of Current Trends in United States Mesothelimoa Incidence. Am J Epidemiol. 1997;211-18.
14. Ilg AGS, Bignon J, Valleron AJ. Estimation of the past and future burden of mortality from mesothelioma in France. Occup Environ Med. 1998;55:760-65.
15. Peto J, Decarli A, Vecchia CL, Levi F, Negri E. The European mesothelimoa epidemic. Br J Cancer. 1999;79:666-72.
16. Segura O, Burdorf A, Looman C. Update of predictions of mortality from pleural mesothelioma in the Netherlands. Occup Environ Med. 2003;60:50-55.
17. Marinaccio A, Montanaro F, Mastrantonio M, et al. Predictions of mortality from pleural mesothelioma in Italy: a model based on asbestos consumption figures supports results from age-period-cohort models. Int J Cancer. 2005;115:142-47.
18. Hodgson JT, McElvenny DM, Darnton AJ, Price MJ, Peto J. The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050. Br J Cancer. 2005;92:587-93.
19. Takahashi K, Huuskonen M, Tossavainen A, Higashi T, Okubo T, Rantanen J. Ecological Relationship between Mesothelioma Incidence/Mortality and Asbestos Consumption in Ten Western Countries and Japan. J Occup Health.. 1999;41:8-11.
20. Kazan-Allen L. Asbestos and mesothelioma: Worldwide trends. Lung Cancer. 2005;49 (suppl 1):S3-S8.
21. Lin RT, Takahashi K, Karjalainen A, et al. Ecological association between asbestos-related diseases and historical asbestos consumption: an international analysis. Lancet. 2007;369:844-49.
22. Banaei A, Auvert B, Goldberg M, Gueguen A, Luce D, Goldberg S. Future trends in mortality of French men from mesothelioma. Occup Environ Med. 2000;57:488-94.
23. Gardner MJ, Saracci R. Effects on health of non-occupational exposure to airborne mineral fibers. IARC Sci Publ. 1989;90:375-97.
24. Iwatsubo Y, Pairon JC, Boutin C, et al. Case-Control Study Pleural Mesothelioma: Dose-Response Relation at Low Levels of Asbestos Exposure in a French Population-based. Am J Epidemiol. 1998;148:133-42.
25. Hillerdal G. Mesothelioma: cases associated with non-occupational and low dose exposures. Occup Environ Med. 1999;56:505-13.
26. Shishido S, Iwai K, Tsukagoshi K. Ferruginous bodies in the lungs of the general population during a 45-year period and mineralogical examination. Nihon Kyobu Shikkan Gakkai Zasshi. 1990;28:473-80.
27. Tachiyama Y, Izumi K, Kawanishi M. Secular Trends in Incidence and Degree of Concentration of Asbestos Bodies in Autopsied Lungs in Hiroshima Prefecture (1957-1987). Hiroshima Journal of Medical Sciences. 1990;38:25-33.
28. Mori Y, Kamiura T, Teraminami Y, Tanaka M. Airborne Asbestos Concentrations of Various Locations in Osaka. Annual Report of Osaka City Institute of Public Health and Environmental Sciences. 1982;44:24-28.
29. Osaka City. Osaka City White Paper on the Environment in 2007. Osaka: Osaka City Environment Bureau; 2008. [in Japanese]
30. Metropolis of Tokyo. Asbestos: Q&A. Ver.2.2.7. Tokyo: Metropolis of Tokyo; 2008. [in Japanese]
31. Watanabe T, Asakuno K, Tamura T, Ishii K, Kan M, Yoshino N. Annual Change of Ambient Air Asbestos in Tokyo Area. Annual Report of the Tokyo Metropolitan Research Institute for Environmental Protection. 1989: 67-69.
32. Watanabe T, Kamataki H, Akiyama K, Asakuno K, Adachi H, Yoshino N. Asbestos Concentration in Tokyo. Annual Report of the Tokyo Metropolitan Research Institute for Environmental Protection. 1994:7-14.
33. Hyogo Prefecture. Hyogo Prefecture White Paper on the Environment. Yearly progress report from 1988 to 2008. Hyogo: Hyogo Prefecture: 1988 to 2008. [in Japanese]
34. Amagasaki City. Amagasaki Environment. Amagasaki: Amagasaki City Environmental Citizens Bureau; 2008. [in Japanese]
35. Mizoguchi K. A study on urban environmental air pollution by asbestos. Japanese Journal of Public Health. 1969; 16: 428. [in Japanese]
36. Mizoguchi K. Asbestos in urban environmental air. Digest of Science of Labour. 1971;26:34-37. [in Japanese]
37. Japan Asbestos Association. Japanese asbestos imports. Tokyo: Japan Asbestos Association; 2007. [in Japanese]
38. Koshi S. Spreading prevention measures of asbestos in dismantlement and the removal of buildings. debrief report of projects sponsored by Environment Agency. Osaka: CRC Research Institute; 1996. [in Japanese]
39. Furuya S, Natori Y, Ikeda R. Asbestos in Japan. Int J Occup Environ Health. 2003;9:260-265.
40. Environment Agency. Report on asbestos monitoring program in 1985. Sangyo Kougai. 1987;23:327-329. [in Japanese]
41. Ministry of the Environment. Result of the emergency survey on asbestos environmental air in 2005. Journal of Environmental Chemistry. 2006;16:471-73. [in Japanese]
42. Nicholson WJ. Airborne Asbestos Health Assessment Update. Report 600/8-84-003F, Washington, DC: United States Environmental Protection Agency; 1986.
43. Osaka. Report of field survey on health effects due to asbestos in Osaka. Tokyo. Environmental Management Bureau, Ministry of the Environment; 2007. [in Japanese]
44. Committee on health effects due to asbestos. Overview of field survey on health effects due to asbestos in Hyogo. Journal of Environmental Chemistry. 2006;16:474-81. [in Japanese]
45. Saga. Report of field survey on health effects due to asbestos in Saga. Tokyo. Environmental Management Bureau, Ministry of the Environment; 2007. [in Japanese]
46. Peto J. Dose-response relationships for asbestos-related disease: implications for hygiene standards. Part II. Mortality. Ann NY Acad Sci. 1979;330:195-203.
47. Peto J, Handerson B, Pike M, et al, eds. Quantification of occupational cancer. Trends in mesothelioma incidence in the US and the forecast epidemic due to asbestos exposure during World War II. Banbury report no 9. Cold Spring Harbor: Cold Spring Harbor Laboratory, 1981: 51-72.
48. Ilgren EB, Wagner JC. Background Incidence of Mesothelioma: Animal and Human Evidence. Regul Toxicol Pharmacol. 1991;13:133-49.
49. McDonald JC, McDonald AD. The epidemiology of mesothelioma in historical context. Eur Respir. J 1996;9:1932-42.
50. Lynch DW, Lewis TR, Moorman WJ, et al. Carcinogenic and toxicologic effects of inhaled ethylene oxide and propylene oxide in F344 rats. Toxicol Appl Pharmacol. 1984;76:69-84.
51. Crosby LM, Morgan KT, Gaskill B, Wolf DC, DeAngelo AB. Origin and distribution of potassium bromate-induced testicular and peritoneal mesotheliomas in rats. Toxicol Pathol. 2000;28:253-66.
52. Nagano K, Umeda Y, Senoh H, et al. Carcinogenicity and chronic toxicity in rats and mice exposed by inhalation to 1,2-dichloroethane for two years. J Occup Health. 2006;48:424-36.
53. Donna A, Betta PG, Robutti F, Bellingeri D. A one-year carcinogenicity study with 2,6-dichlorobenzonitrile (Dichlobenil) in male Swiss mice: preliminary note. Cancer Detect Prev. 1991;15:41-44.
54. National Toxicology Program. NTP Toxicology and Carcinogenesis Studies of Methyleugenol (CAS NO. 93-15-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies). Natl Toxicol Program Tech Rep Ser. 2000;491:1-412.
55. Rice JM, Kovatch RM, Anderson LM. Intraperitoneal mesotheliomas induced in mice by a polycyclic aromatic hydrocarbon. J Toxicol Environ Health. 1989;27:153-60.
56. Hughes RS. Malignant pleural mesothelioma. Am J Med Sci. 2005;329:29-44.